Advertisement
Screener

RadNet, Inc. (RDNT) Operating Lease Right-of-Use Assets

2.8 / 5 stars · 68/120 Roast Me

RadNet, Inc. Operating Lease Right-of-Use Assets

RadNet, Inc. (RDNT) had Operating Lease Right-of-Use Assets of $759.23 million as of 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Balance Sheet › Assets › Assets, Noncurrent

us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-10

  • 2026-06-30: Operating Lease, Right-of-Use Asset $759.23M.
  • 2026-03-31: Operating Lease, Right-of-Use Asset $760.98M.
  • 2025-12-31: Operating Lease, Right-of-Use Asset $690.25M.
  • 2025-09-30: Operating Lease, Right-of-Use Asset $675.33M.
Period endOperating Lease, Right-of-Use Asset
2026-06-30$759.23M
10-Q · filed 2026-08-10
2026-03-31$760.98M
10-Q · filed 2026-05-11
2025-12-31$690.25M
10-Q · filed 2026-08-10
2025-09-30$675.33M
10-Q · filed 2025-11-10
2025-06-30$666.05M
10-Q · filed 2025-08-11
2025-03-31$665.75M
10-Q · filed 2025-05-12
2024-12-31$639.74M
10-K · filed 2026-03-02
2024-09-30$646.75M
10-Q · filed 2024-11-12
2024-06-30$624.08M
10-Q · filed 2024-08-09
2024-03-31$621.61M
10-Q · filed 2024-05-10
2023-12-31$596.03M
10-K · filed 2025-03-03
2023-09-30$613.16M
10-Q · filed 2023-11-09
2023-06-30$627.13M
10-Q · filed 2023-08-09
2023-03-31$623.31M
10-Q · filed 2023-05-10
2022-12-31$603.52M
10-K · filed 2024-02-29
2022-09-30$631.34M
10-Q · filed 2022-11-09
2022-06-30$635.22M
10-Q · filed 2022-08-09
2022-03-31$595.79M
10-Q · filed 2022-05-10
2021-12-31$584.29M
10-K · filed 2023-03-01
2021-09-30$577.71M
10-Q · filed 2021-11-09
2021-06-30$593.57M
10-Q · filed 2021-08-09
2021-03-31$529.56M
10-Q · filed 2021-05-10
2020-12-31$483.66M
10-K · filed 2022-03-01
2020-09-30$451.61M
10-Q · filed 2020-11-09
2020-06-30$448.86M
10-Q · filed 2020-08-10
2020-03-31$435.38M
10-Q · filed 2020-05-11
2019-12-31$445.48M
10-K · filed 2021-03-16
2019-09-30$438.56M
10-Q · filed 2019-11-12
2019-06-30$432.56M
10-Q · filed 2019-08-09
2019-03-31$403.07M
10-Q · filed 2019-05-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70